Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt-Koyanagi-Harada disease

The British Journal of Ophthalmology
Yoshikatsu HosodaShoji Kuriyama

Abstract

To investigate the effectiveness of isolated subtenon triamcinolone acetonide injection (STI) as a primary treatment in eyes with acute Vogt-Koyanagi-Harada (VKH) disease. Retrospective, observational, cross-sectional study. The data from 27 eyes in 14 patients with acute VKH treated with STI therapy were analysed retrospectively. The time course change in ocular inflammation, best corrected visual acuity (BCVA) and numbers of recurrences were examined. STI led to prompt improvement of BCVA within a week after the primary treatment. After completing therapy, patients with VKH had improved BCVA compared with baseline. In six eyes of three patients (22.2%) treated with STI, ocular inflammation was refractory, or VKH was recurrent despite the treatment. There was significant difference between groups with and without recurrences of inflammation in the frequency of headaches before treatment. In the present study, 21 eyes of 11 patients (77.8%) achieved complete resolution of VKH without recurrence after STI therapy alone. This study demonstrated that isolated STI therapy is a useful, minimally invasive, primary treatment option for patients with acute VKH without systemic disorders.

References

May 1, 1991·Archives of Ophthalmology·P E Rubsamen, J D Gass
Jan 1, 1990·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Y SasamotoH Matsuda
Jan 20, 1972·The New England Journal of Medicine·A LoredoL Murillo
Sep 1, 1972·American Journal of Ophthalmology·J Herschler
Oct 1, 1980·Archives of Ophthalmology·H W Skalka, J T Prchal
Jan 1, 1995·Survey of Ophthalmology·R S MoorthyN A Rao
Mar 1, 1996·Irish Medical Journal·N TubridyM O'Connor
Jul 26, 2003·The British Journal of Ophthalmology·A A OkadaT Hida
Sep 10, 1960·JAMA : the Journal of the American Medical Association·R L BLACKJ J BUNIM
Mar 12, 2004·American Journal of Ophthalmology·Rafael E AndradeRubens Belfort
Apr 6, 2005·American Journal of Ophthalmology·Akitaka TsujikawaYasuo Kurimoto
Nov 29, 2005·American Journal of Ophthalmology·Marc D de Smet, Narsing A Rao
Jun 9, 2006·European Journal of Ophthalmology·M KaracorluH Ozdemir
Oct 24, 2007·International Ophthalmology·Irfan PerenteOmer Faruk Yilmaz
Aug 28, 2010·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Simon R J TaylorSue Lightman
Feb 5, 2014·American Journal of Ophthalmology·Yoshikatsu HosodaNagahisa Yoshimura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here